He X - Search Results

1

Mesenchymal stem cells overexpressing IL-35 effectively inhibit CD4⁺ T cell function.

Zhao N, Li H, Yan Y, Jiang R, He X. Zhao N, et al. Among authors: he x. Cell Immunol. 2017 Feb;312:61-66. doi: 10.1016/j.cellimm.2016.12.001. Epub 2016 Dec 8. Cell Immunol. 2017. PMID: 27993351

2

Amplified interleukin-15 expression vectors for cancer immunogene therapy.

He X, Li W, Lu N, Qi F, Zhao N, Qiu Y, Zhu L. He X, et al. Mol Med Rep. 2008 May-Jun;1(3):369-74. Mol Med Rep. 2008. PMID: 21479419

3

Inhibition of colon tumor growth by IL-15 immunogene therapy.

He X, Li W, Wang Y, Hou L, Zhu L. He X, et al. Mol Med Rep. 2012 Jan;5(1):96-102. doi: 10.3892/mmr.2011.601. Epub 2011 Sep 27. Mol Med Rep. 2012. PMID: 21956355

4

Interleukin-15 gene therapy and the mammalian target of rapamycin inhibitor everolimus inhibit the growth of metastatic breast cancer.

Zhao N, Li X, He X, Qiu Y, Zhu L, Qi F. Zhao N, et al. Among authors: he x. J Gene Med. 2013 Oct;15(10):366-74. doi: 10.1002/jgm.2739. J Gene Med. 2013. PMID: 24038990

5

Inhibiting cardiac allograft rejection with interleukin-35 therapy combined with decitabine treatment in mice.

Guo H, Wang W, Zhao N, He X, Zhu L, Jiang X. Guo H, et al. Among authors: he x. Transpl Immunol. 2013 Dec;29(1-4):99-104. doi: 10.1016/j.trim.2013.10.001. Epub 2013 Oct 6. Transpl Immunol. 2013. PMID: 24103733

6

Goiter and hearing impairment: A case of a male patient with Pendred syndrome.

Hu EW, Liu LB, Jiang RY, He XH. Hu EW, et al. Oncol Lett. 2014 Nov;8(5):2059-2062. doi: 10.3892/ol.2014.2461. Epub 2014 Aug 19. Oncol Lett. 2014. PMID: 25295090 Free PMC article.

7

Cell fusion between gastric epithelial cells and mesenchymal stem cells results in epithelial-to-mesenchymal transition and malignant transformation.

He X, Li B, Shao Y, Zhao N, Hsu Y, Zhang Z, Zhu L. He X, et al. BMC Cancer. 2015 Jan 30;15:24. doi: 10.1186/s12885-015-1027-1. BMC Cancer. 2015. PMID: 25633122 Free PMC article.

8

Evidence of cell fusion in carcinogen-induced mice gastric carcinoma.

Yan Y, Hsu Y, He X, Lu N, Wei W, Zhang Z, Zhu L. Yan Y, et al. Among authors: he x. Tumour Biol. 2015 Jul;36(7):5089-94. doi: 10.1007/s13277-015-3160-5. Epub 2015 Feb 6. Tumour Biol. 2015. PMID: 25656611

9

Engineered cytotoxic T lymphocytes with AFP-specific TCR gene for adoptive immunotherapy in hepatocellular carcinoma.

Sun L, Guo H, Jiang R, Lu L, Liu T, He X. Sun L, et al. Among authors: he x. Tumour Biol. 2016 Jan;37(1):799-806. doi: 10.1007/s13277-015-3845-9. Epub 2015 Aug 7. Tumour Biol. 2016. PMID: 26250457

10

Artificial antigen-presenting cells expressing AFP(158-166) peptide and interleukin-15 activate AFP-specific cytotoxic T lymphocytes.

Sun L, Guo H, Jiang R, Lu L, Liu T, Zhang Z, He X. Sun L, et al. Among authors: he x. Oncotarget. 2016 Apr 5;7(14):17579-90. doi: 10.18632/oncotarget.8198. Oncotarget. 2016. PMID: 27007051 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

29,195 results

Search Page

Filters